Shares of Genus plc (LON:GNS) have received a consensus rating of “Buy” from the six ratings firms that are covering the stock, reports. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company.

Several equities analysts have weighed in on the company. Liberum Capital restated a “buy” rating on shares of Genus plc in a research note on Tuesday, May 2nd. Peel Hunt restated a “buy” rating on shares of Genus plc in a research note on Thursday, June 1st.

Shares of Genus plc (LON:GNS) traded up 1.09% during trading on Friday, reaching GBX 1758.00. 10,641 shares of the company were exchanged. The company’s market capitalization is GBX 1.07 billion. The firm’s 50 day moving average price is GBX 1,783.86 and its 200 day moving average price is GBX 1,785.88. Genus plc has a one year low of GBX 1,671.72 and a one year high of GBX 2,113.00.

ILLEGAL ACTIVITY NOTICE: “Genus plc (GNS) Given Average Recommendation of “Buy” by Brokerages” was published by American Banking News and is owned by of American Banking News. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The legal version of this story can be accessed at

Genus plc Company Profile

Genus plc is an animal genetics company, which provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. The Company’s segments include Genus PIC, Genus ABS, Genus Asia, and Research and Development. The Genus PIC segment is engaged in porcine sales business, excluding Asia, and serves porcine customers in North America, Latin America and Europe.

Analyst Recommendations for Genus plc (LON:GNS)

Receive News & Ratings for Genus plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus plc and related companies with's FREE daily email newsletter.